NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway

Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignant tumors. The involvement of N-myc (and STAT) interactor (NMI) and its possible functional mechanisms in HCC progression still remain to be elucidated. In this study, we found that NMI was overexpressed in metastatic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Zhao, Jing, Dong, Qiong-Zhu, Zhong, Fan, Cai, Li-Li, Qin, Zhao-Yu, Liu, Yang, Lin, Cheng-Zhao, Qin, Lun-Xiu, He, Fu-Chu
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355334/
https://ncbi.nlm.nih.gov/pubmed/28077802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14556
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares